Literature DB >> 19420316

Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection.

Maria Sala1, Mercè Comas, Francesc Macià, Juan Martinez, Montserrat Casamitjana, Xavier Castells.   

Abstract

PURPOSE: To compare the effect of the introduction of digital mammography on the recall rate, detection rate, false-positive rate, and rates of invasive procedures performed in the first and successive rounds of a population-based breast cancer screening program with double reading in Barcelona, Spain.
MATERIALS AND METHODS: The study was approved by the ethics committee; informed consent was not required. Data were compared from 12,958 women aged 50-69 years old who participated in a screening round before the introduction of digital mammography (screen-film mammography group) with data from 6074 women who participated in another screening round after the introduction of digital mammography (digital mammography group). Groups were compared for recall rate and detection rate stratified according to first or successive screening rounds, and logistic regression analysis was performed.
RESULTS: Overall recall rates for screen-film and digital mammography groups were 5.5% and 4.2%, respectively (P < .001). The recall rate was higher in the first screening round (11.5% and 11.1% in the screen-film mammography and digital mammography groups, respectively; P = .68) than in successive screening rounds (3.6% and 2.4% in the screen-film mammography and digital mammography groups, respectively; P < .001). The main factors related to the risk of recall were screen-film mammography group (odds ratio = 1.28), first screening round (odds ratio = 3.53), menopausal status (odds ratio = 0.62), and history of personal benign breast disease (odds ratio = 2.26). No significant differences were found in the cancer detection rate between groups. In the first screening round, this rate was higher in the digital than in the screen-film mammography group (1.1% and 0.4%, respectively; P = .009). The invasive test rate was 2.6% and 1.3% in the screen-film and digital mammography groups, respectively (P < .001) and was lower with digital mammography than with screen-film mammography in both the first and successive screening rounds.
CONCLUSION: Digital mammography may reduce the adverse effects of screening programs if this technique is confirmed to have the same diagnostic accuracy as screen-film mammography. (c) RSNA, 2009.

Entities:  

Mesh:

Year:  2009        PMID: 19420316     DOI: 10.1148/radiol.2521080696

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  Impact of the Introduction of Digital Mammography in an Organized Screening Program on the Recall and Detection Rate.

Authors:  Cinzia Campari; Paolo Giorgi Rossi; Carlo Alberto Mori; Sara Ravaioli; Andrea Nitrosi; Rita Vacondio; Pamela Mancuso; Antonella Cattani; Pierpaolo Pattacini
Journal:  J Digit Imaging       Date:  2016-04       Impact factor: 4.056

2.  Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography.

Authors:  Solveig Hofvind; Per Skaane; Joann G Elmore; Sofie Sebuødegård; Solveig Roth Hoff; Christoph I Lee
Journal:  Radiology       Date:  2014-04-01       Impact factor: 11.105

3.  Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study.

Authors:  Karla Kerlikowske; Rebecca A Hubbard; Diana L Miglioretti; Berta M Geller; Bonnie C Yankaskas; Constance D Lehman; Stephen H Taplin; Edward A Sickles
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

4.  Measurement of breast tissue composition with dual energy cone-beam computed tomography: a postmortem study.

Authors:  Huanjun Ding; Justin L Ducote; Sabee Molloi
Journal:  Med Phys       Date:  2013-06       Impact factor: 4.071

5.  Differences in radiological patterns, tumour characteristics and diagnostic precision between digital mammography and screen-film mammography in four breast cancer screening programmes in Spain.

Authors:  Laia Domingo; Anabel Romero; Francesc Belvis; Mar Sánchez; Joana Ferrer; Dolores Salas; Josefa Ibáñez; Alfonso Vega; Francesc Ferrer; M Soledad Laso; Francesc Macià; Xavier Castells; Maria Sala
Journal:  Eur Radiol       Date:  2011-05-11       Impact factor: 5.315

6.  Impact of the digitalisation of mammography on performance parameters and breast dose in the Flemish Breast Cancer Screening Programme.

Authors:  Lore Timmermans; An De Hauwere; Klaus Bacher; Hilde Bosmans; Kim Lemmens; Luc Bleyen; Erik Van Limbergen; Patrick Martens; Andre Van Steen; Griet Mortier; Koen Van Herck; Hubert Thierens
Journal:  Eur Radiol       Date:  2014-05-10       Impact factor: 5.315

7.  Breast tissue characterization with photon-counting spectral CT imaging: a postmortem breast study.

Authors:  Huanjun Ding; Michael J Klopfer; Justin L Ducote; Fumitaro Masaki; Sabee Molloi
Journal:  Radiology       Date:  2014-05-07       Impact factor: 11.105

8.  Technical and clinical breast cancer screening performance indicators for computed radiography versus direct digital radiography.

Authors:  Hilde Bosmans; An De Hauwere; Kim Lemmens; Federica Zanca; Hubert Thierens; Chantal Van Ongeval; Koen Van Herck; Andre Van Steen; Patrick Martens; Luc Bleyen; Gretel Vande Putte; Eliane Kellen; Griet Mortier; Erik Van Limbergen
Journal:  Eur Radiol       Date:  2013-05-21       Impact factor: 5.315

9.  Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.

Authors:  Lore Timmermans; Luc Bleyen; Klaus Bacher; Koen Van Herck; Kim Lemmens; Chantal Van Ongeval; Andre Van Steen; Patrick Martens; Isabel De Brabander; Mathieu Goossens; Hubert Thierens
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

Review 10.  Is the false-positive rate in mammography in North America too high?

Authors:  Michelle T Le; Carmel E Mothersill; Colin B Seymour; Fiona E McNeill
Journal:  Br J Radiol       Date:  2016-06-08       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.